Cargando…
Evaluation of cystatin C activities against HIV
BACKGROUND & OBJECTIVES: Several host defense proteins known to possess antimicrobial activities are present on mucosal surfaces and are consequently found in body fluids of vertebrates. Naturally occurring protease inhibitors like cystatins, especially cystatin C (cys C), are abundantly present...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510722/ https://www.ncbi.nlm.nih.gov/pubmed/26112843 http://dx.doi.org/10.4103/0971-5916.159282 |
_version_ | 1782382225818386432 |
---|---|
author | Vernekar, Vandana Velhal, Shilpa Bandivdekar, Atmaram |
author_facet | Vernekar, Vandana Velhal, Shilpa Bandivdekar, Atmaram |
author_sort | Vernekar, Vandana |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Several host defense proteins known to possess antimicrobial activities are present on mucosal surfaces and are consequently found in body fluids of vertebrates. Naturally occurring protease inhibitors like cystatins, especially cystatin C (cys C), are abundantly present in human seminal plasma. Although its antiviral activity against herpes simplex virus (HSV) has been demonstrated, the role of this protein against HIV is not well studied. Therefore, the aim of the present study was to evaluate the anti-HIV activities of cys C, which is present innately in the male reproductive tract. METHODS: Protein-protein interaction of cys C with various HIV proteins was studied using a commercially available HIV blot and specific interaction with HIV protease was studied by dot-blot technique using commercially available cys C. To purify biologically active cys C from human seminal plasma to be used for subsequent experiments, gel-permeation chromatography followed by affinity chromatography was used. The HIV infectivity inhibition activity of the purified cystatin C was tested in TZM-bl cells. To study its activity on HIV protease, time-course enzyme kinetics studies were performed using spectrometric assay. RESULTS: Cystatin C reacted with some HIV proteins including HIV protease. Biologically active cys C was purified using gel permeation chromatography followed by affinity chromatography. When tested in TZM-bl cells, purified cystatin C demonstrated HIV-infectivity inhibitory activity (IC(50): 0.28 μM). Enzyme kinetic studies demonstrated that it abrogated the action of HIV protease on its substrate. INTERPRETATION & CONCLUSIONS: The present data demonstrate that cystatin C possesses anti-HIV activities. Molecular models need to be designed with this protein which would assist towards prevention/therapeutics against HIV. |
format | Online Article Text |
id | pubmed-4510722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45107222015-07-30 Evaluation of cystatin C activities against HIV Vernekar, Vandana Velhal, Shilpa Bandivdekar, Atmaram Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Several host defense proteins known to possess antimicrobial activities are present on mucosal surfaces and are consequently found in body fluids of vertebrates. Naturally occurring protease inhibitors like cystatins, especially cystatin C (cys C), are abundantly present in human seminal plasma. Although its antiviral activity against herpes simplex virus (HSV) has been demonstrated, the role of this protein against HIV is not well studied. Therefore, the aim of the present study was to evaluate the anti-HIV activities of cys C, which is present innately in the male reproductive tract. METHODS: Protein-protein interaction of cys C with various HIV proteins was studied using a commercially available HIV blot and specific interaction with HIV protease was studied by dot-blot technique using commercially available cys C. To purify biologically active cys C from human seminal plasma to be used for subsequent experiments, gel-permeation chromatography followed by affinity chromatography was used. The HIV infectivity inhibition activity of the purified cystatin C was tested in TZM-bl cells. To study its activity on HIV protease, time-course enzyme kinetics studies were performed using spectrometric assay. RESULTS: Cystatin C reacted with some HIV proteins including HIV protease. Biologically active cys C was purified using gel permeation chromatography followed by affinity chromatography. When tested in TZM-bl cells, purified cystatin C demonstrated HIV-infectivity inhibitory activity (IC(50): 0.28 μM). Enzyme kinetic studies demonstrated that it abrogated the action of HIV protease on its substrate. INTERPRETATION & CONCLUSIONS: The present data demonstrate that cystatin C possesses anti-HIV activities. Molecular models need to be designed with this protein which would assist towards prevention/therapeutics against HIV. Medknow Publications & Media Pvt Ltd 2015-04 /pmc/articles/PMC4510722/ /pubmed/26112843 http://dx.doi.org/10.4103/0971-5916.159282 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Vernekar, Vandana Velhal, Shilpa Bandivdekar, Atmaram Evaluation of cystatin C activities against HIV |
title | Evaluation of cystatin C activities against HIV |
title_full | Evaluation of cystatin C activities against HIV |
title_fullStr | Evaluation of cystatin C activities against HIV |
title_full_unstemmed | Evaluation of cystatin C activities against HIV |
title_short | Evaluation of cystatin C activities against HIV |
title_sort | evaluation of cystatin c activities against hiv |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510722/ https://www.ncbi.nlm.nih.gov/pubmed/26112843 http://dx.doi.org/10.4103/0971-5916.159282 |
work_keys_str_mv | AT vernekarvandana evaluationofcystatincactivitiesagainsthiv AT velhalshilpa evaluationofcystatincactivitiesagainsthiv AT bandivdekaratmaram evaluationofcystatincactivitiesagainsthiv |